ArticleFrontiers in immunology2024

Germline DNA damage response gene mutations as predictive biomarkers of immune checkpoint inhibitor efficacy.

Michael J Dennis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.